Many people ask what the bladder cancer survival rates are for their race/ethnicity. A large part of this statistic is due to different ways of calculating the numbers. Some statistics are based on overall survival and some are based on survival by type. Some are looking at age of onset and others are looking at whether or not the cancer has spread (areas that remain unaffected by treatment). There are also statistical analyses that look at where the patient was diagnosed, whether or not he/she is still undergoing treatment and so forth.
Overall, racial differences for bladder cancer survival rates have been previously reported only for Caucasians and African Americans. But the statistical analysis of Asian and Pacific Islander patients has not been fully analyzed. It’s important to note that while Caucasians/ Africans are relatively youthful when diagnosed, they are typically diagnosed with higher grade cancers (i.e., bladder cancer stages 3 and above) at a later time.
Asian and Pacific Islander patients statistically have the highest bladder cancer survival rates. The reasons for this vary according to which group you look at. For example, Caucasians/ Africans has a higher overall death rate, which is because of higher rates of many other diseases. As well, Caucasians/ Africans has higher percentages of people who die from other cancers at the same age (i.e., stomach and esophageal cancer), which account for their high overall bladder cancer survival rates. Also, they have higher percentages of men with this disease.
The five-year survival rate for African American patients has not been examined, but studies have shown a positive survival rate. Overall, however, they do not have the best survival rates among all ethnicities. This has also been attributed to the fact that many of them are diagnosed with a higher-grade tumor (which carries a greater chance of being able to be treated and cured). Treatment options are often limited due to the aggressive nature of these types of bladder cancer treatments.
Asian patients, on the other hand, have the lowest five-year survival rate of all ethnic groups. Patients, who are diagnosed with adenocarcinoma, have an increased chance of being cured if they receive early diagnosis and undergo treatment. But even if they are diagnosed with adenocarcinoma, they still have a good five-year survival rate. The reason for this is due to the use of targeted immunoexpression score therapy, or TOSH, as a treatment.
Transient carcinoma also known as transitional cell carcinoma is the second most common type of bladder cancer. This occurs in areas of the body where there is excessive growth of cells (such as lymphomas and tumors) that are not part of the typical sites of cell division such as the lungs, heart, pancreas, or gastrointestinal tract. These tumors usually grow slowly over a period of time and can be detected only when they’re very large. The most common type of transitional cell carcinoma is squamous cell carcinoma.
There are several factors that contribute to the survival rates of people with this type of cancer. First, survival rates increase slightly with age and the length of time the person has had the cancer. Second, younger patients tend to respond better to treatment. And third, once intravesical chemotherapy has begun, survival rates stay high even with later stages of the disease. In addition, bladder cancer responds very well to surgery.
There are many different factors that contribute to survival rates. Age and the amount of time spent with the cancer, however, are two of the most important. Age and log-rank are related to the accuracy of the log-rank analysis and are considered extremely important in determining the overall survival rate of patients with this type of cancer. Patients who survive their first treatment are also at an advantage because they have more time to learn about the treatments and their expected outcomes.